Gain Therapeutics GANX
NASDAQ GANX
$1.11 +0.03 (+2.78%)
At close: Nov 11, 2026 · 4:00 PM EST

Gain Therapeutics (GANX) Receivables - Net (2020 - 2021)

Updated

Gain Therapeutics (GANX) reported Receivables - Net of $24,713 for Q3 2021, down 93.0% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Receivables - Net (2020 - 2021) Analysis & Trends

At the end of FY2020, Gain Therapeutics posted Receivables - Net of $8,548.

  • Five-year quarterly Receivables - Net spans a low of $4,486 in Q1 2021 and a high of $353,166 in Q2 2021.
  • Per Business Quant data, the three quarters before Q3 2021 came in at $353,166 (Q2 2021), $4,486 (Q1 2021) and $8,548 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Gain Therapeutics 47.87 Mn -14.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 24,713.00
Jun 30, 2021 353,166.00
Mar 31, 2021 4,486.00
Dec 31, 2020 8,548.00
API Access

Gain Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=GANX&period=max&api_key=YOUR_API_KEY